Multiple Sclerosis Therapy Consensus Group (MSTCG): position statement on disease-modifying therapies for multiple sclerosis (white paper).

H. Wiendl; R. Gold; T. Berger; T. Derfuss; R. Linker; M. Mäurer; O. Aktas; K. Baum; M. Berghoff; S. Bittner; A. Chan; A. Czaplinski; F. Deisenhammer; F. Di Pauli; R. Du Pasquier; C. Enzinger; E. Fertl; A. Gass; K. Gehring; C. Gobbi; N. Goebels; M. Guger; A. Haghikia; H.P. Hartung; F. Heidenreich; O. Hoffmann; B. Kallmann; C. Kleinschnitz; L. Klotz; V.I. Leussink; F. Leutmezer; V. Limmroth; J.D. Lünemann; A. Lutterotti; S.G. Meuth; U. Meyding-Lamadé; M. Platten; P. Rieckmann; S. Schmidt; H. Tumani; F. Weber; M.S. Weber; U.K. Zettl; T. Ziemssen; F. Zipp

Multiple Sclerosis Therapy Consensus Group (MSTCG): position statement on disease-modifying therapies for multiple sclerosis (white paper).

Fiche du document

Auteurs

Date

2021

Discipline

Histoire, Philosophie et Sociologie des sciences

Types de document

Périmètre

Publications

Langue

Anglais

Identifiants

doi: 10.1177/17562864211039648
issn: 1756-2856

Source

Serveur académique Lausannois

Relations

Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.1177/17562864211039648

Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/34422112

Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pissn/1756-2856

Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_D4CA9A6A86B82

Collection

Serveur Académique Lausannois

Organisation

Université de Lausanne et CHUV

Licences

info:eu-repo/semantics/openAccess , CC BY-NC 4.0 , https://creativecommons.org/licenses/by-nc/4.0/

Mots-clés 0

disease-modifying therapy; guideline; multiple sclerosis; treatment recommendation

Sujets proches En

Sclerosis, Multiple MS (Disease)

Citer ce document

H. Wiendl et al., « Multiple Sclerosis Therapy Consensus Group (MSTCG): position statement on disease-modifying therapies for multiple sclerosis (white paper). », Serveur académique Lausannois, ID : 10.1177/17562864211039648

Partage / Export

Résumé 0

Multiple sclerosis is a complex, autoimmune-mediated disease of the central nervous system characterized by inflammatory demyelination and axonal/neuronal damage. The approval of various disease-modifying therapies and our increased understanding of disease mechanisms and evolution in recent years have significantly changed the prognosis and course of the disease. This update of the Multiple Sclerosis Therapy Consensus Group treatment recommendation focuses on the most important recommendations for disease-modifying therapies of multiple sclerosis in 2021. Our recommendations are based on current scientific evidence and apply to those medications approved in wide parts of Europe, particularly German-speaking countries (Germany, Austria, and Switzerland).

{"uri":"10.1177\/17562864211039648","titles":["Multiple Sclerosis Therapy Consensus Group (MSTCG): position statement on disease-modifying therapies for multiple sclerosis (white paper)."],"disciplines":[{"uri":"http:\/\/aurehal.archives-ouvertes.fr\/subject\/shs.hisphilso","label":{"fr":"Histoire, Philosophie et Sociologie des sciences","es":"Historia, Filosof\u00eda y Sociolog\u00eda de las Ciencias","en":"History, Philosophy and Sociology of Sciences"}}],"creators":[{"id":"wiendl_h","lastname":"Wiendl"},{"id":"gold_r","lastname":"Gold"},{"id":"berger_t","lastname":"Berger"},{"id":"derfuss_t","lastname":"Derfuss"},{"id":"linker_r","lastname":"Linker"},{"id":"maurer_m","lastname":"M\u00e4urer"},{"id":"aktas_o","lastname":"Aktas"},{"id":"baum_k","lastname":"Baum"},{"id":"berghoff_m","lastname":"Berghoff"},{"id":"bittner_s","lastname":"Bittner"},{"id":"chan_a","lastname":"Chan"},{"id":"czaplinski_a","lastname":"Czaplinski"},{"id":"deisenhammer_f","lastname":"Deisenhammer"},{"id":"di_pauli_f","lastname":"Di Pauli"},{"id":"du_pasquier_r","lastname":"Du Pasquier"},{"id":"enzinger_c","lastname":"Enzinger"},{"id":"fertl_e","lastname":"Fertl"},{"id":"gass_a","lastname":"Gass"},{"id":"gehring_k","lastname":"Gehring"},{"id":"gobbi_c","lastname":"Gobbi"},{"id":"goebels_n","lastname":"Goebels"},{"id":"guger_m","lastname":"Guger"},{"id":"haghikia_a","lastname":"Haghikia"},{"id":"hartung_h_p","lastname":"Hartung"},{"id":"heidenreich_f","lastname":"Heidenreich"},{"id":"hoffmann_o","lastname":"Hoffmann"},{"id":"kallmann_b","lastname":"Kallmann"},{"id":"kleinschnitz_c","lastname":"Kleinschnitz"},{"id":"klotz_l","lastname":"Klotz"},{"id":"leussink_v_i","lastname":"Leussink"},{"id":"leutmezer_f","lastname":"Leutmezer"},{"id":"limmroth_v","lastname":"Limmroth"},{"id":"lunemann_j_d","lastname":"L\u00fcnemann"},{"id":"lutterotti_a","lastname":"Lutterotti"},{"id":"meuth_s_g","lastname":"Meuth"},{"id":"meyding_lamade_u","lastname":"Meyding-Lamad\u00e9"},{"id":"platten_m","lastname":"Platten"},{"id":"rieckmann_p","lastname":"Rieckmann"},{"id":"schmidt_s","lastname":"Schmidt"},{"id":"tumani_h","lastname":"Tumani"},{"id":"weber_f","lastname":"Weber"},{"id":"weber_m_s","lastname":"Weber"},{"id":"zettl_u_k","lastname":"Zettl"},{"id":"ziemssen_t","lastname":"Ziemssen"},{"id":"zipp_f","lastname":"Zipp"}]}

Multiple Sclerosis Therapy Consensus Group (MSTCG): position statement on disease-modifying therapies for multiple sclerosis (white paper).

Fiche du document

Mots-clés 0

Sujets proches En

Citer ce document

Métriques

Partage / Export

Résumé 0

Par les mêmes auteurs

Sur les mêmes sujets

Sur les mêmes disciplines

Exporter en